Selected article for: "IFN production and virus replication"

Author: Heaton, Steven M.; Borg, Natalie A.; Dixit, Vishva M.
Title: Ubiquitin in the activation and attenuation of innate antiviral immunity
  • Document date: 2016_1_11
  • ID: 42d77vxf_39
    Snippet: cIAP2 is an E3 that, after itself being ubiquitinated by TRAF6, targets TRAF3 for degradation (Tseng et al., 2010) . This is important in promoting TLR4-mediated signaling and cytokine production at the expense of type I IFN production . Furthermore, TRAF6 itself promotes proinflammatory cytokine production at the expense of IFN-I. TRAF6 is activated by trans-autoubiquitination at K124, abolition of which eliminates NEMO ubiquitination and TAK1 a.....
    Document: cIAP2 is an E3 that, after itself being ubiquitinated by TRAF6, targets TRAF3 for degradation (Tseng et al., 2010) . This is important in promoting TLR4-mediated signaling and cytokine production at the expense of type I IFN production . Furthermore, TRAF6 itself promotes proinflammatory cytokine production at the expense of IFN-I. TRAF6 is activated by trans-autoubiquitination at K124, abolition of which eliminates NEMO ubiquitination and TAK1 activation (Lamothe et al., 2007) . This mechanism is exploited by HSV, which uses the virally encoded E3 infected cell polypeptide 0 (ICP0) to recruit USP7 to deubiquitinate NEMO and TRAF6 (Daubeuf et al., 2009 ). In addition, ICP0 directly catalyzes ubiquitination and degradation of MyD88 and TIR AP (Toll/interleukin-1 receptor domain-containing adaptor protein; van Lint et al., 2010) . Kaposi's sarcoma-associated herpesvirus (KSHV) encodes replication and transcription factor (RTA), an E3 that activates latent virus. This activation process involves suppression of antiviral cytokines, partly involving RTA-catalyzed ubiquitination and degradation of MyD88 and TRIF (Ahmad et al., 2011; Zhao et al., 2015) , thereby impairing all TLR-mediated immune signaling pathways.

    Search related documents:
    Co phrase search for related documents
    • activation process and cell polypeptide: 1
    • activation process and cytokine production: 1
    • activation process and cytokine signaling: 1, 2
    • activation process and immune signaling pathway: 1, 2
    • adaptor protein and cytokine production: 1, 2, 3, 4
    • adaptor protein and cytokine signaling: 1, 2, 3
    • adaptor protein and cytokine signaling production: 1, 2
    • adaptor protein and degradation ubiquitination: 1, 2, 3, 4
    • adaptor protein and ifn production: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • antiviral cytokine and cytokine production: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral cytokine and cytokine signaling: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral cytokine and cytokine signaling production: 1
    • antiviral cytokine and degradation ubiquitination: 1
    • antiviral cytokine and ifn production: 1, 2, 3, 4, 5, 6, 7
    • cell polypeptide and infected cell polypeptide: 1, 2
    • cytokine production and degradation ubiquitination: 1, 2, 3
    • cytokine production and ifn production: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cytokine production and immune signaling pathway: 1, 2, 3, 4
    • cytokine signaling and latent virus activate: 1